by In2Pharma | Jul 13, 2026 | News
Luxembourg On 10 June 2026, the General Assembly of Innovative Medicines for Luxembourg (IML) approved a revised version of the IML Code of Ethics. The updated code introduces several targeted changes, including new provisions on complaints, a dedicated patient...
by In2Pharma | Jun 4, 2026 | News
Belgium The Belgian Health Authorities (FAMHP) have recently published a guidance document on the interpretation of Article 10 of the Law of 25 March 1964 regarding premiums and benefits. This document aims to further clarify the legal framework governing the granting...
